Global Prescription Drugs Market : Industry Analysis and Forecast (2020-2026) – by Therapy, Distribution Channel and Region.

The Global Prescription Drugs Market size is expected to reach US$ XX Mn. by 2026 from US$ XX Mn. in 2019, at a CAGR 8.5% during the forecast period. The report focuses on prescription drug market value at the top regions and countries of the world, which shows a regional development, including market size, share, revenue, and much more across the globe. The report has covered, capacity, production value, cost/profit, and supply/demand by statistical analysis. A brief analysis of drivers, restraints, opportunities, and challenges in the market is also covered with examples by region. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments. It also has covered the analysis of key player’s growth strategies, micro and macro analysis of markets, key developments, and key trends in the market.

Global Prescription Drugs Market Dynamics:

Stringent regulation supports the growth of the global prescription drugs market, thanks to the reports revealed by the Food And Drug Law Institute, in the US, the Federal Food, Drug, and Cosmetic Act (FDCA) and Title 21 of the Code of Federal Regulations Part 202 (21 CFR Part 202) mainly govern prescription drug advertising and promotion. Besides that, in Chile, prescription drug advertising and promotion is monitored and regulated by the Agencia Nacional de Medicamentos (ANAMED), also recognized as the National Drug Agency. ANAMED is a part of the Institute of Public Health (ISP) and is responsible for the control of pharmaceuticals, cosmetics, and medical devices, guaranteeing their quality, safety, and effectiveness. The increasing launches of the generic equivalents of numerous key drugs in developed markets such as the U.S., because these generics are often as efficient as their original counterparts. Patients without access to costly prescription products due to financial hurdles can often adopt these drugs and experience better clinical conclusions. For example, in 2019, the U.S. FDA announced that they had given 1,171 generic drug approvals out of which 935 were full approvals and 236 were tentative approvals. The high costs associated with many prescription drugs, due to the increasing incidence of critical diseases such as cancers, and cardiovascular diseases worldwide, and the higher prevalence of these conditions in developing regions such as Africa, Latin America, and Asia. For instance, Abiraterone used in the treatment of prostate cancer can cost the patient US$ 10,000/ month at its lowest and not even cure the disease.

Global Prescription Drugs Market Segment Overview:

By therapy, the prescription drugs market is segmented into oncology, anti-diabetics, vaccines, sensory organs, immunosuppressant, anticoagulants, and others. Among these, the oncology segment is expected to hold the largest market share of the global market, because of the increasing prevalence of cancer, and the high costs attributed to the treatment of several forms of cancer. The anti-diabetics segment is also expected to grow at the highest CAGR of XX% during the forecast period, due to the increasing prevalence of diabetes, and other lifestyle-associated diseases. Based on the distribution channel, the prescription drugs market is segmented into retail pharmacies, hospital pharmacies & drug stores, and online pharmacies. The hospital pharmacies & drug stores segment is held the largest market share of the global market in 2019 and is expected to retain its steady position during the forecast period (2020-2026).This is mainly because the therapeutics indicated under prescription drugs can often be only prescribed in hospital settings under the guidance of trained medical professionals. A large number of availabilities of over-the-counter drugs, together with the growing need for daily medications such as anti-diabetics, are otherkey factors accountable for the growth of the hospital pharmacies & drug stores segment in the forecast period (2020-2026). Global Prescription Drugs Market To Know About The Research Methodology :- Request Free Sample Report

Global Prescription Drugs Market Regional Insights:

Global Prescription Drugs Market1 North America is expected to hold the largest market share for the prescription drugs market by 2026. This growth is attributed to the stringent regulations on the promotion and advertising of prescription drugs.Also, the increasing demand for efficient and advanced products in North Americaparticularly due to the high prevalence of several chronic diseases. These factors, along with high healthcare expenditure, strong R&D for drugs in North America, and the presence of key companies in North America involved in the production of generic equivalents of key drugs. Europe is the second-largest market in the global market, thanks to the increased demand for innovative prescription products and the product launches of efficient prescription products including orphan drugs. Also, Asia-Pacific is expected to hold the highest CAGR of XX% during the forecast period (2020-2026). This is mainly because of the new launches of key products in Asia-Pacific and the strong demand for prescription drugs. The objective of the report is to present a comprehensive analysis of the Global Prescription Drugs Market to the stakeholders in the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Prescription DrugsMarket dynamics, structure by analyzing the market segments and project the Global Prescription Drugs Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Prescription Drugs Market make the report investor’s guide.

Global Prescription Drugs Market Scope: Inquire before buying

Global Prescription Drugs Market2

Global Prescription Drugs Market, by Region

• North America • Europe • Asia Pacific • Middle East & Africa • South America

Global Prescription Drugs Market Key Players

• Novartis AG • Pfizer Inc. • F.Hoffmann-La Roche Ltd • Sanofi • Johnson & Johnson Services, Inc. • Merck & Co., Inc. • Abbvie, Inc. • AstraZeneca • GlaxoSmithKline plc. • CELGENE CORPORATION (BRISTOL-MYERS SQUIBB COMPANY) • Lupin Pharmaceuticals, Inc. • Dr Reddy’s Laboratories Ltd • Allergan • Shire • Boehringer Ingelheim • Takeda • Eli Lilly • Myers Squibb • AbbVie • Gilead Sciences • Teva • Novo Nordisk • Amgen • Roche

Global Prescription Drugs Market

1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Prescription Drugs Market Size, by Market Value (US$ Bn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2019 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Prescription Drugs Market 3.4. Geographical Snapshot of the Prescription Drugs Market, By Manufacturer share 4. Global Prescription Drugs Market Overview, 2019-2026 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Prescription Drugs Market 5. Supply Side and Demand Side Indicators 6. Global Prescription Drugs Market Analysis and Forecast, 2019-2026 6.1. Global Prescription Drugs Market Size & Y-o-Y Growth Analysis. 7. Global Prescription Drugs Market Analysis and Forecasts, 2019-2026 7.1. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 7.1.1. Oncology 7.1.2. Anti-diabetics 7.1.3. Vaccines 7.1.4. Sensory organs 7.1.5. Immunosuppressant’s 7.1.6. Anticoagulants 7.1.7. Others 7.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 7.2.1. Hospital Pharmacies 7.2.2. Retail Pharmacies & Drug Stores 7.2.3. Online Pharmacies 8. Global Prescription Drugs Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2019-2026 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Prescription Drugs Market Analysis and Forecasts, 2019-2026 9.1. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 9.1.1. Oncology 9.1.2. Anti-diabetics 9.1.3. Vaccines 9.1.4. Sensory organs 9.1.5. Immunosuppressant’s 9.1.6. Anticoagulants 9.1.7. Others 9.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 9.2.1. Hospital Pharmacies 9.2.2. Retail Pharmacies & Drug Stores 9.2.3. Online Pharmacies 10. North America Prescription Drugs Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Prescription Drugs Market Analysis and Forecasts, 2019-2026 11.1. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 11.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 12. Canada Prescription Drugs Market Analysis and Forecasts, 2019-2026 12.1. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 12.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 13. Mexico Prescription Drugs Market Analysis and Forecasts, 2019-2026 13.1. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 13.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 14. Europe Prescription Drugs Market Analysis and Forecasts, 2019-2026 14.1. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 14.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 15. Europe Prescription Drugs Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Prescription Drugs Market Analysis and Forecasts, 2019-2026 16.1. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 16.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 17. France Prescription Drugs Market Analysis and Forecasts, 2019-2026 17.1. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 17.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 18. Germany Prescription Drugs Market Analysis and Forecasts, 2019-2026 18.1. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 18.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 19. Italy Prescription Drugs Market Analysis and Forecasts, 2019-2026 19.1. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 19.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 20. Spain Prescription Drugs Market Analysis and Forecasts, 2019-2026 20.1. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 20.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 21. Sweden Prescription Drugs Market Analysis and Forecasts, 2019-2026 21.1. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 21.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 22. CIS Countries Prescription Drugs Market Analysis and Forecasts, 2019-2026 22.1. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 22.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 23. Rest of Europe Prescription Drugs Market Analysis and Forecasts, 2019-2026 23.1. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 23.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 24. Asia Pacific Prescription Drugs Market Analysis and Forecasts, 2019-2026 24.1. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 24.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 25. Asia Pacific Prescription Drugs Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Prescription Drugs Market Analysis and Forecasts, 2019-2026 26.1. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 26.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 27. India Prescription Drugs Market Analysis and Forecasts, 2019-2026 27.1. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 27.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 28. Japan Prescription Drugs Market Analysis and Forecasts, 2019-2026 28.1. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 28.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 29. South Korea Prescription Drugs Market Analysis and Forecasts, 2019-2026 29.1. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 29.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 30. Australia Prescription Drugs Market Analysis and Forecasts, 2019-2026 30.1. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 30.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 31. ASEAN Prescription Drugs Market Analysis and Forecasts, 2019-2026 31.1. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 31.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 32. Rest of Asia Pacific Prescription Drugs Market Analysis and Forecasts, 2019-2026 32.1. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 32.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 33. Middle East Africa Prescription Drugs Market Analysis and Forecasts, 2019-2026 33.1. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 33.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 34. Middle East Africa Prescription Drugs Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Prescription Drugs Market Analysis and Forecasts, 2019-2026 35.1. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 35.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 36. GCC Countries Prescription Drugs Market Analysis and Forecasts, 2019-2026 36.1. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 36.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 37. Egypt Prescription Drugs Market Analysis and Forecasts, 2019-2026 37.1. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 37.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 38. Nigeria Prescription Drugs Market Analysis and Forecasts, 2019-2026 38.1. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 38.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 39. Rest of ME&A Prescription Drugs Market Analysis and Forecasts, 2019-2026 39.1. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 39.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 40. South America Prescription Drugs Market Analysis and Forecasts, 2019-2026 40.1. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 40.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 41. South America Prescription Drugs Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Prescription Drugs Market Analysis and Forecasts, 2019-2026 42.1. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 42.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 43. Argentina Prescription Drugs Market Analysis and Forecasts, 2019-2026 43.1. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 43.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 44. Rest of South America Prescription Drugs Market Analysis and Forecasts, 2019-2026 44.1. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 44.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Prescription Drugs Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. Novartis AG 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Pfizer Inc. 45.3.3. F.Hoffmann-La Roche Ltd 45.3.4. Sanofi 45.3.5. Johnson & Johnson Services, Inc. 45.3.6. Merck & Co., Inc. 45.3.7. Abbvie, Inc. 45.3.8. AstraZeneca 45.3.9. GlaxoSmithKline plc. 45.3.10. CELGENE CORPORATION (BRISTOL-MYERS SQUIBB COMPANY) 45.3.11. Lupin Pharmaceuticals, Inc. 45.3.12. Dr Reddy’s Laboratories Ltd 45.3.13. Allergan 45.3.14. Shire 45.3.15. Boehringer Ingelheim 45.3.16. Takeda 45.3.17. Eli Lilly 45.3.18. Myers Squibb 45.3.19. AbbVie 45.3.20. Gilead Sciences 45.3.21. Teva 45.3.22. Novo Nordisk 45.3.23. Amgen 45.3.24. Roche 46. Primary Key Insights

About This Report

Report ID 92903
Category Healthcare
Published Date April 2021
Updated Date
Contact Us